Esokalli Slimming Microcrystalline Patch
Product Images NDC 84778-082

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Esokalli Slimming Microcrystalline Patch (NDC 84778-082). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Guangzhou Yixin Cross-border E-commerce Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (20250828 01)

1 (20250828 01)
This is a description for a Slimming Microcrystalline Patch that supports weight management by using Retatrutide 20mg with soluble microneedle technology for long-acting sustained-release delivery. The patch is designed for adults with type 2 diabetes mellitus to help with weight management and blood sugar control when used alongside diet and exercise. It is important to monitor blood glucose regularly while using the patch, and any severe abdominal pain or breathing difficulties should prompt stopping its use and consulting a doctor. The patch should be applied once a week on the wrist or back of the body for best results. It is for external use only and should be kept out of reach of children. The patch contains active ingredient Retatrutide 20mg for weight management and blood sugar control, along with inactive ingredients like Microcrystal needle polymer blend and stabilizers.*
FDA Label Image

2 (20250828 02)

2 (20250828 02)
This text describes a slimming microcrystalline patch that supports weight management. The patch contains Retatrutide 20mg, utilizes soluble microneedle technology for long-acting sustained delivery, and should be applied once a week. The product is primarily used for weight management and sugar control when accompanied by diet and exercise. It also includes warnings for external use only, instructions for adults to apply one patch to the wrist or back, and to keep it away from children. The text provides information on drug facts, purposes, directions, and inactive ingredients.*
FDA Label Image

3 (20250828 03)

3 (20250828 03)
Description: The Slimming Microcrystalline Patch is designed to support weight management through the unique Core Technology and Soluble Microneedle Technology. Each patch contains 20mg of Retatrutide, aimed at aiding in weight management and blood sugar control. With a once-a-week application for long-acting sustained release, this product offers convenience for users looking to enhance their diet and exercise regimen. Remember to use it externally only and seek medical advice if severe symptoms occur. The patch's soluble microneedle polymer blend ensures effective delivery and performance.*
FDA Label Image

4 (20250828 04)

4 (20250828 04)
The text describes a slimming microcrystalline patch for weight management and glycemic control. It is intended to improve blood sugar control, when used with diet and exercise, by providing long-acting sustained release through a microneedle patch. The product contains Retotrutide as the active ingredient. It warns against potential side effects such as hypoglycemia, acute pancreatitis, and allergic reactions. The directions include applying one patch every 3 to 7 days and seeking medical advice before use in certain medical conditions. The patch should be applied in the morning and removed after 30-60 minutes. It is recommended to store the product in a cool, dry place away from moisture and sunlight and out of reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.